RMD is no longer actively traded. Data shown reflects verified historical relationships.
4Suppliers
7Customers
1Debt Items
19Related Chains

ResMed Inc. Suppliers

TickerNameConfidenceEvidence
BRIGHTREE BRIGHTREE 90% Following multiple acquisitions, including Brightree in 2016, HEALTHCARE first and MatrixCare in 2018, and MEDIFOX DAN in November 2022, we now provide OOH software products designed to support the p…
HEALTHCAREFIRST HEALTHCAREFIRST 90% Following multiple acquisitions, including Brightree in 2016, HEALTHCARE first and MatrixCare in 2018, and MEDIFOX DAN in November 2022, we now provide OOH software products designed to support the p…
MATRIXCARE MATRIXCARE 90% Following multiple acquisitions, including Brightree in 2016, HEALTHCARE first and MatrixCare in 2018, and MEDIFOX DAN in November 2022, we now provide OOH software products designed to support the p…
MEDIFOX-DAN MEDIFOX-DAN 90% Following multiple acquisitions, including Brightree in 2016, HEALTHCARE first and MatrixCare in 2018, and MEDIFOX DAN in November 2022, we now provide OOH software products designed to support the p…

ResMed Inc. Customers

TickerNameConfidenceEvidence
APYX Apyx Medical Corporation 62% mpetitors are affiliates of our customers, which may make it difficult to compete with them. Our primary Sleep and Respiratory Care competitors include Philips BV; Fisher & Paykel Healthcare Corporat…
APYX Apyx Medical Corporation 62% Reciprocal relationship from APYX graph: Reciprocal relationship from RMD graph: Reciprocal relationship from APYX graph: Reciprocal relationship from RMD graph: Reciprocal relationship from APYX gra…
BMC-MEDICAL-CO-LTD BMC-MEDICAL-CO-LTD 62% mpetitors are affiliates of our customers, which may make it difficult to compete with them. Our primary Sleep and Respiratory Care competitors include Philips BV; Fisher & Paykel Healthcare Corporat…
MEDIFOX-DAN-INVESTMENT-GMBH MEDIFOX-DAN-INVESTMENT-GMBH 62% Item 8 RESMED INC. AND SUBSIDIARIES Notes to the Consolidated Financial Statements (17) Business Combinations On November 21, 2022, we completed our acquisition of 100 % of the shares in MediFox-Dan …
PAYKEL-HEALTHCARE-CORPORATION-LIMITED PAYKEL-HEALTHCARE-CORPORATION-LIMITED 62% mpetitors are affiliates of our customers, which may make it difficult to compete with them. Our primary Sleep and Respiratory Care competitors include Philips BV; Fisher & Paykel Healthcare Corporat…
REACT-HEALTH-CORPORATION REACT-HEALTH-CORPORATION 62% mpetitors are affiliates of our customers, which may make it difficult to compete with them. Our primary Sleep and Respiratory Care competitors include Philips BV; Fisher & Paykel Healthcare Corporat…
SUPPLY-CO-LTD SUPPLY-CO-LTD 62% Item 1 RESMED INC. AND SUBSIDIARIES Our primary Sleep and Breathing Health competitors include Philips BV; Fisher & Paykel Healthcare Corporation Limited; DeVilbiss Healthcare; Apex Medical Corporati…

ResMed Inc. Debt Obligations

InstrumentDescriptionConfidenceEvidence
RMD-DEBT Debt stack $843.2M 90% Market cache reports total debt of $843.2M.

ResMed Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for ResMed Inc..

ResMed Inc. Ownership

HolderNameConfidenceEvidence
RMD-OWNER-VANGUARD-GROUP-INC VANGUARD GROUP INC 90% 13F overlay lists VANGUARD GROUP INC as top holder; 941 tracked holders.

ResMed Inc. Extended Supply Chain Network

TickerNameChain IndexHopsRelationship Types
CAJPY Canon Inc. 100.00 2
CAJFF Canon Inc. 100.00 2
INMD InMode Ltd. 100.00 2
HTFL Heartflow, Inc. 100.00 2
HSCS HeartSciences Inc. 100.00 2
RSMDF ResMed Inc. 100.00 2
MICC The Magnum Ice Cream Company N.V. 100.00 2
DFDV DeFi Development Corp. 50.00 2
INGN Inogen, Inc. 50.00 2
PUK Prudential plc 50.00 2
PHG Koninklijke Philips N.V. 50.00 2
INTC Intel Corporation 50.00 2
NVSEF Novartis AG 50.00 2
RAY Raytech Holding Limited 50.00 2
RYLPF Koninklijke Philips N.V. 38.88 1 ['receiving']
APYX Apyx Medical Corporation 28.83 1 ['customer']
JNJ Johnson & Johnson 14.78 2
GAP The Gap, Inc. 14.78 2
FMS Fresenius Medical Care AG 14.78 2